The Vanguard Group 13D/13G Filings for Carisma Therapeutics, Inc. (CARM)

The Vanguard Group 13D and 13G filings for Carisma Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-13
5:00 pm
Purchase
2023-12-29 13G Carisma Therapeutics, Inc.
CARM
The Vanguard Group 1,568,761
3.890%
1,568,761increase
(New Position)
Filing